Immunotherapy of house dust mite allergy
House dust mite (HDM) is a predominant source of indoor aeroallergen worldwide, which induces allergic diseases including allergic rhinoconjunctivitis, allergic asthma, atopic eczema and other allergic skin diseases. Allergen specific immunotherapy (AIT) is the only potential disease-modifying treat...
Saved in:
Main Authors: | Lin Yang (Author), Rongfei Zhu (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New approaches to immunotherapy in house dust mite allergy
by: In Sik Kim
Published: (2023) -
Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
by: Yaqi Yang, et al.
Published: (2021) -
Climate change and house-dust mite allergy
by: Denis Charpin
Published: (2021) -
The Prevention of House Dust Mite Allergies in Pediatric Asthma
by: Angela Klain, et al.
Published: (2024) -
The molecular diagnosis of house dust mite allergy: a short review
by: Magdalena Choina, et al.
Published: (2022)